These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9811057

  • 1. Treatment of rheumatoid synovitis with anti-reshaping human interleukin-6 receptor monoclonal antibody: use of rheumatoid arthritis tissue implants in the SCID mouse model.
    Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H, Nishimoto N, Yoshizaki K.
    Arthritis Rheum; 1998 Nov; 41(11):2014-21. PubMed ID: 9811057
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of CD147/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis.
    Jia J, Wang C, Shi Z, Zhao J, Jia Y, Zhao-Hui Z, Li X, Chen Z, Zhu P.
    Rheumatology (Oxford); 2009 Jul; 48(7):721-6. PubMed ID: 19429906
    [Abstract] [Full Text] [Related]

  • 3. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
    Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H.
    Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
    [Abstract] [Full Text] [Related]

  • 4. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T.
    J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
    [Abstract] [Full Text] [Related]

  • 5. Requirement of methotrexate in combination with anti-tumor necrosis factor-alpha therapy for adequate suppression of osteoclastogenesis in rheumatoid arthritis.
    Matsuno H, Yoshida K, Ochiai A, Okamoto M.
    J Rheumatol; 2007 Dec; 34(12):2326-33. PubMed ID: 18050387
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis.
    Nakazawa F, Matsuno H, Yudoh K, Katayama R, Sawai T, Uzuki M, Kimura T.
    J Rheumatol; 2001 Aug; 28(8):1800-8. PubMed ID: 11508582
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis.
    Sakai K, Matsuno H, Morita I, Nezuka T, Tsuji H, Shirai T, Yonehara S, Hasunuma T, Nishioka K.
    Arthritis Rheum; 1998 Jul; 41(7):1251-7. PubMed ID: 9663483
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis.
    Matsuno H, Yudoh K, Uzuki M, Nakazawa F, Sawai T, Yamaguchi N, Olsen BR, Kimura T.
    J Rheumatol; 2002 May; 29(5):890-5. PubMed ID: 12022345
    [Abstract] [Full Text] [Related]

  • 12. Gene transfer to human rheumatoid synovial tissue engrafted in SCID mice.
    Jorgensen C, Demoly P, Noel D, Mathieu M, Piechaczyc M, Gougat C, Bousquet J, Sany J.
    J Rheumatol; 1997 Nov; 24(11):2076-9. PubMed ID: 9375863
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T.
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synovial tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of SCID.bg mice.
    Sack U, Kuhn H, Ermann J, Kinne RW, Vogt S, Jungmichel D, Emmrich F.
    J Rheumatol; 1994 Jan; 21(1):10-6. PubMed ID: 8151561
    [Abstract] [Full Text] [Related]

  • 18. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
    Pallua N, Low JF, von Heimburg D.
    Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.